Angela Watson

Doctor of Osteopathic Medicine,  Toronto General - University Health Network 

Location: United States

Consulting Services

Career Advice and Mentoring IT-Web-Mobile Technology Research Consulting

Areas Of Interest

Partusisten Vineyard Goblet Cell Carcinoid Storage Device, Optical Employee Participation Case Studies, Organizational Thistles, Golden Clostridium perfringens Infections Tyrosinoses, Oculocutaneous Type Coriolaceae Anaphylatoxin Inactivator Virus, Turkey Pox Residencies, Non-Medical Patched Homolog-2 Pathogenicity Aqueduct of Vestibule Endo beta N Acetylglucosaminidase F Amyloidoses Bisphosphonate-Related Osteonecrosis of the Jaw Scintigraphies, Gated Blood-Pool Seizures, Somatosensory Ratio, Base Sequential Organ Failure Assessment Scores Gene Gun DNA Immunization Ellis-Van Creveld Dysplasia Wrong Site Surgery Seizure, Febrile, Simple CoA-Reductase, NAD-Dependent 3-Hydroxy-3-methylglutaryl beta-Hydroxy-5 beta-Androstan-3-One, 17 D-Thyroxine Refraction, Double

Professional Narrative

Dr. Angela Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Harvard Med 1993
Assistant Professor, Amgen 2001

Education

Master of Science in physician assistant, Yale School of Medicine 1996
Bachelor of science in nursing, Harvard Medical School 2008

Referees


Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :